Olon Acquires Huvepharma Italia
Olon continues its growth path and increases its total production capacity following the acquisition of Huvepharma Italia and its site in Garessio, Cuneo, in the northwestern part of Italy.
Contract Development And Manufacturing Organizations (CDMO)
Bora Completes Buy of Emergent’s US Sterile Fill/Finish Site
Bora Pharmaceuticals, a Taiwan-headquartered contract development and manufacturing organization (CDMO), has completed the acquisition of Emergent BioSolutions' sterile manufacturing facility in Baltimore-Camden, Maryland, USA. The facility adds drug product fill/finish to Bora’s extensive biologics drug substance capabilities.
The Shifting CDMO Leadership Landscape
A recent report by consulting company WittKiefer delves into the role of CDMOs within the pharmaceutical industry, evaluating the effectiveness of existing leadership structures and expertise in navigating market complexities.
Touchlight and GSK Sign License Agreement for DNA Production
Touchlight, a UK-based custom development and manufacturing organization (CDMO) specializing in enzymatic DNA production, signed a license agreement with British drugmaker GSK which grants GSK non-exclusive rights to use Touchlight’s proprietary enzymatic dbDNA (doggybone DNA) technology for the development and production of mRNA-based products.
Agilent to Buy Canadian CDMO Biovectra for $925 Million
Santa Clara, CA-based Agilent Technologies has signed a definitive agreement to acquire specialized contract development and manufacturing organization Biovectra from H.I.G. Capital in a move to expand its end-to-end biopharma solutions.
Veranova Appoints Cécile Maupas as Senior Vice President, Chief Commercial Officer
Veranova, a development and manufacturing of specialist and complex APIs for the pharmaceutical and biotech sectors, recently announced the appointment of Cécile Maupas as Senior Vice President, Chief Commercial Officer.
CordenPharma Invests €900 Million in Peptide Platform Expansion
CordenPharma announced its largest strategic investment to date, committing to spend ~€900m over the next three years to enhance its peptide technology platform.
Navin Molecular Plans €32.6 Million Expansion of GMP Manufacturing
Navin Molecular, an Indian-headquartered CDMO with small molecule development and manufacturing capabilities, recently announced a Rs 288 Crore (approximately €32.6 million/$35 million) investment to construct a 9,000 m2 GMP manufacturing plant in Dewas, India. The new facility will nearly double the overall capacity at the site to 420 m3. It will support existing commercial-scale projects and meet future demands as the company continues to expand its global customer base.
SK Bioscience Acquires Majority Stake in IDT Biologika
South Korea-headquartered contract development and manufacturing organization (CDMO) SK Bioscience plans to acquire a 60% stake in IDT Biologika, a German CDMO specialized in vaccines, gene and immune therapy and oncolytic viruses, from Klocke Group. Klocke will retain a 40% stake in IDT Biologika and thus remains the company's second-largest shareholder.
Veranova Expands ADC and HPAPI Capabilities in the US
US contract development and manufacturing organization (CDMO) Veranova has initiated an expansion of its antibody-drug conjugate (ADC) and highly potent active pharmaceutical ingredient (HPAPI) development and manufacturing capabilities at its US facility in Devens, Massachusetts.
Siegfried to Buy Early-Phase CDMO Site from Curia
Zofingen, Switzerland-based contract development and manufacturing organization (CDMO) Siegfried has signed a binding agreement to acquire an early-phase CDMO site in Grafton, Wisconsin, US, from Curia. The transaction is expected to close by July 1, subject to customary closing conditions.
Siegfried to Acquire Early-Phase CDMO in US
Siegfried, a global Contract Development and Manufacturing Organization (CDMO) for the pharmaceutical industry headquartered in Zofingen, Switzerland, has signed binding agreements with Curia Global for the acquisition of an early-phase CDMO site in Grafton, Wisconsin, US.
Aurigene Opens Biologics Facility
Aurigene Pharmaceutical Services Limited (Aurigene), a Dr. Reddy’s Laboratories Limited company, inaugurated its biologics facility spread across 6500 m2 (70,000 sq ft) in Hyderabad, India.
Sterling Expands HPAPI Capabilities at US Facility
UK-headquartered contract development and manufacturing organization (CDMO) Sterling Pharma Solutions has invested $3 million at its US facility in Germantown, WI, to expand the company’s integrated antibody-drug conjugate (ADC) development and manufacturing capabilities.
Kühne Holding Acquires Aenova from BC Partners
Kühne Holding has agreed to purchase Aenova Group, a pharma contract development and manufacturing organization (CDMO), from BC Partners. BC will reinvest and retain a minority stake in Aenova. The financial terms remain undisclosed.
Fujifilm Invests Additional $1.2 Billion in CDMO Business in North Carolina
Fujifilm announced an additional investment of $1.2 billion in its large-scale cell culture contract development and manufacturing organization (CDMO) business to further expand the planned Fujifilm Diosynth Biotechnologies facility in Holly Springs, North Carolina, bringing the total investment in the facility to over $3.2 billion. Plans for the new site were unveiled in September last year.
Upperton Opens New Development and GMP Manufacturing Facility
Upperton Pharma Solutions was joined by Sarah Gilbert, Professor and co-creator of the Oxford/AstraZeneca COVID-19 vaccine for the official opening of its new development and GMP manufacturing facility in Nottingham, UK.
A New Standard of Collaboration for the Pharmaceutical Industry
Headquartered in Cramlington, UK, Sterling Pharma Solutions is a contract development and manufacturing organization (CDMO) that provides a range of services to the global biopharmaceutical industry, including active pharmaceutical ingredient (API) development, scale-up and cGMP manufacturing, as well as antibody drug conjugate (ADC) R&D and clinical-scale GMP manufacturing.
Antheia and Olon Continue Biomanufacturing Partnership
US biotech company Antheia and Olon, an Italian producer of active pharmaceutical ingredients (APIs), have announced the continuation of their ongoing partnership to utilize Olon’s fermentation infrastructure for the scale-up and commercialization of Antheia’s early products.
Novo Holdings to Acquire Catalent for $16.5 Billion
Novo Holdings, Novo Nordisk's parent company, is acquiring US contract development and manufacturing organization (CDMO) Catalent for $16.5 billion. The companies said that Novo Holdings will acquire all outstanding shares of Catalent for $63.50 per share in cash.
Siegfried Announces Changes in Senior Management Team
Siegfried has appointed Marianne Späne, currently chief business officer Drug Products, as chief business officer with responsibility for both the Drug Substances and Drug Products divisions of the Swiss contract manufacturing and development organization (CDMO), effective Feb. 1, 2024. Christian Dowdeswell, who previously led the Drug Substance business, has decided to leave Siegfried.
Veranova Appoints Chris Holmes as Vice President, Global Engineering
Veranova has appointed Chris Holmes as the company’s first vice president, Global Engineering. He will lead Veranova’s global engineering team in the planning, design, and execution of the company’s capital investment initiatives and lead strategic capital projects.
Lonza and Oxford Nanopore to Collaborate on mRNA Analysis
Swiss contract development and manufacturing organization (CDMO) Lonza will collaborate with Oxford Nanopore Technologies, a UK-based company delivering a new generation of nanopore-based molecular sensing technology. The collaboration aims to cGMP validate and commercialize a first-of-its-kind novel test to accurately determine multiple critical quality attributes of mRNA products by directly sequencing both the DNA template and the messenger RNA (mRNA).
EuroAPI Collaborates with Contract Research Organization SpiroChem
Active pharmaceutical ingredients manufacturer EuroAPI has started a collaboration with Basel, Switzerland-headquartered SpiroChem, a contract research organization (CRO) which specializes in early chemical process R&D (route scouting).
WuXi Biologics Expands Production Capacity at Massachusetts Site
China-headquartered contract research, development and manufacturing organization (CRDMO) WuXi Biologics plans to increase the manufacturing capacity of its US facility in Worcester, Massachusetts to 36,000 l, 12,000 l more than the originally planned 24,000 l.
CordenPharma & pHLIP Form RNA & Gene Delivery Alliance
CordenPharma and pHLIP have announced their strategic alliance to collaborate in developing and commercializing the pHLIP-LNP targeted delivery platform for RNA-based and genetic therapeutics.
EuroAPI Appoints Ludwig de Mot as Chief Transformation Officer
EuroAPI has appointed Ludwig de Mot as chief transformation officer and executive vice president (EVP).
Biosynth Acquires VIO Chemicals
Swiss Biosynth, a supplier of raw materials to the life science industry, has acquired VIO Chemicals, a Zurich, Switzerland-based company with leading chemical R&D expertise and a global network of large-scale manufacturing partners. Financial details of the transaction have not been disclosed.
Lucas Sauer-Jones Appointed as Vice President & General Manager of Veranova’s New England Sites
US API maker Veranova has appointed Lucas Sauer-Jones as the company’s vice president & general manager, New England. He will be responsible for Veranova’s sites in Devens and North Andover.
Unleashing CDMO Growth through Effective Pricing
In the rapidly evolving industry of contract development and manufacturing organizations (CDMOs), a well-defined pricing strategy is essential to drive growth and profitability. To stay ahead and participate in the expansion of the market, CDMOs need to transition to a structured value-based pricing approach that considers customer value, complexity, and specific needs.
EuroAPI Completes Acquisition of BianoGMP
EuroAPI has completed the acquisition of BianoGMP, a contract development and manufacturing organization (CDMO) specializing in oligonucleotides.
AGC Expands Production Capacity for Agrochemicals and Pharmaceuticals in Japan
AGC Wakasa Chemicals, part of Japanese group AGC, has completed a new large-scale production line at its Kaminaka Plant in Fukui prefecture, Japan, as it expects demand for agrochemicals and pharmaceuticals to grow steadily against a backdrop of population growth and improvement of living standards.
Olon to Nearly Double Production Capacity of Indian Site
Olon, an Italian CDMO and API producer of active pharmaceutical ingredients (APIs), plans to invest €10 million in a multi-year expansion of its production site in Mahad, India.
Noramco Acquires Drug Product Business Unit from Cambrex
Noramco, a US producer of active pharmaceutical ingredients (APIs), has completed the acquisition of the Cambrex drug product business unit previously known as Halo Pharmaceuticals. Financial details were not disclosed.
Aragen to Invest $30 Million in a New Indian Bio-Manufacturing Site
Aragen, an India, Hyderabad-headquartered contract research development and manufacturing organization (CRDMO) for small molecules and biologics, plans to set up a new biologics manufacturing facility in Bangalore, India.
CPA Chemical Pharmac. Ass.
Brenntag SE
Simon-Kucher & Partners Strategy & Marketing Consultants GmbH
Refeyn Ltd.
DSM Pharmaceutical Products
CHEManager International c/o Wiley-VCH GmbH
HAS Healthcare Advanced Synthesis SA
Axplora
J. Rettenmaier & Söhne GmbH + Co KG
GLSyntech LLC
OneSource Specialty Pharma Limited
CordenPharma International
Resilience
Solvias AG
Patheon Italia
Hovione
Agno Pharma
Catalent Inc.
WittKiefer
Thomson Reuters
Abzena
Saltigo GmbH
Ferak Berlin GmbH
Global Gateway Advisors
Symeres
Frost & Sullivan
Upperton Pharma Solutions
FDA Smart
Fraser Dove International
Northway Biotech
Camelot Management Consultants AG
Arxada AG
Samsung Biologics
Suanfarma
Godrej Astec LifeSciences Limited (Astec Life)
Asahi Kasei Europe
Serán Bioscience, LLC
ICIG
Agilent Technologies Inc.
Ardena
Haltermann Ltd.
Gallus Biopharmaceuticals, LLC
Aenova Holding GmbH
AmbioPharm, Inc.
CatSci Ltd.
Olon S.p.A.
Cambrex Corporation
Codexis
Arthur D. Little
SK Pharmteco